eNeura SpringTMS Post-Market Observational US Study of Migraine
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David W Dodick, MD
Mayo Clinic , Phoenix,AZ
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic
Phoenix, Arizona, United States
- Ucla Headache Research and Treatment Program
Los Angeles, California, United States
- Stanford Headache Program
Stanford, California, United States
- Mid Atlantic Permanente Medical Group-Kaiser
Rockville, Maryland, United States
- Albert Einstein College of Medicine
The Bronx, New York, United States
- the Cleveland Clinic Center for Headache and Pain
Cleveland, Ohio, United States
- Jefferson Headache Center
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Dec 2014
- Primary completion
- 1 Jul 2016
- Completion
- 1 Jul 2016
- Last update posted
- 18 Jun 2021
- Registered enrollment
- 263
- Registry id
- NCT02357381
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.